Activity content starts in:
Industry Webcast
Taking Control: The Urgent Need to Identify and Address Uncontrolled AsthmaIndustry Webcast Sponsored by AstraZeneca; Not for CME/CE Credit
In the United States, the burden of asthma is significant, with exacerbations playing a critical role. Join us to evaluate the clinical merits of the Asthma Impairment and Risk Questionnaire (AIRQ®) over other asthma control tools. By assessing both symptom impairment and exacerbation risk, the AIRQ® can complement current asthma guidelines and facilitate shared decision-making by helping to identify unrecognized asthma morbidity.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 9/25/2025
Expiration Date: 9/25/2025
Topics
Faculty
Supporters and Partners
Industry Sponsor
AstraZeneca
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.